InnoVec Biotherapeutics
Latest round
- Series A
Last raised
- Jun 2025
Total raised
- Undisclosed
Investors
- 2
About InnoVec Biotherapeutics
Established in 2020 and based in Beijing, China, InnoVec Biotherapeutics focuses on the advancement of innovative medical technologies. InnoVec Biotherapeutics specializes in the development and commercialization of innovative medical devices aimed at enhancing patient care and outcomes. The company’s core offerings include advanced diagnostic tools and therapeutic devices that address various healthcare challenges, particularly in chronic disease management and early disease detection. These products support healthcare professionals in delivering effective treatments and improving patient monitoring capabilities. It serves client base including hospitals, outpatient clinics, and healthcare providers primarily in Asia and Europe. It generates revenue through a multifaceted business model that includes direct-to-consumer sales and partnerships with healthcare institutions. Transactions typically involve the sale of proprietary medical devices, priced based on their complexity and technology. Flagship products generally follow a one-time purchase model, while specific diagnostics operate on a subscription basis for ongoing support and updates. The revenue structure also encompasses arrangements with distributors and wholesalers who facilitate the broader market reach of its offerings. InnoVec Biotherapeutics plans to launch new products designed for chronic disease management and expects to release these innovations by mid-2026. The company targets expansion into the Southeast Asian and European markets by the end of 2026.
Who invested in InnoVec Biotherapeutics
2 investors across 3 rounds
See all investors in InnoVec Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about InnoVec Biotherapeutics
Who invested in InnoVec Biotherapeutics?
InnoVec Biotherapeutics has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InnoVec Biotherapeutics raised?
InnoVec Biotherapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did InnoVec Biotherapeutics last raise money?
InnoVec Biotherapeutics's most recent round on record is a Series A, in Jun 2025.
What does InnoVec Biotherapeutics do?
Established in 2020 and based in Beijing, China, InnoVec Biotherapeutics focuses on the advancement of innovative medical technologies.
Where is InnoVec Biotherapeutics headquartered?
InnoVec Biotherapeutics is headquartered in Beijing, China.
Which VCs invest in companies like InnoVec Biotherapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at InnoVec Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like InnoVec Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.